26. Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)32835-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Proteomics Analysis of an UBE3A Knockout Mouse Modelling Angelman Syndrome

English

Tissue-Specific Variation of Ube3a Protein Expression in Rodents and in a Mouse Model of Angelman Syndrome

Neurobiology of Disease
Neurology
2010English

Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells

PLoS ONE
Multidisciplinary
2015English

Mutation Analysis of UBE3A in Angelman Syndrome Patients

American Journal of Human Genetics
Genetics
1998English

Mitochondrial Dysfunction in CA1 Hippocampal Neurons of the UBE3A Deficient Mouse Model for Angelman Syndrome

Neuroscience Letters
Neuroscience
2011English

Corrigendum: Angelman Syndrome-Derived Neurons Display Late Onset of Paternal UBE3A Silencing

Scientific Reports
Multidisciplinary
2018English

A Behavioral Test Battery for Mouse Models of Angelman Syndrome: A Powerful Tool for Testing Drugs and Novel Ube3a Mutants

Molecular Autism
PsychiatryMental HealthDevelopmental NeuroscienceDevelopmental BiologyMolecular Biology
2018English

Ube3a Loss Increases Excitability and Blunts Orientation Tuning in the Visual Cortex of Angelman Syndrome Model Mice

Journal of Neurophysiology
NeurosciencePhysiology
2017English

The Transcription Factor ATF3 Acts as an Oncogene in Mouse Mammary Tumorigenesis

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy